Judicial Panel on Multidistrict Litigation Issues Order on Aflibercept Patent Litigation
April 11, 2024
April 11, 2024
WASHINGTON, April 11 -- The Judicial Panel on Multidistrict Litigation issued the following order (MDL No. 3103):
* * *
In Re: Aflibercept Patent Litigation
TRANSFER ORDER
Before the Panel: Common plaintiff Regeneron Pharmaceuticals, Inc., moves under 28 U.S.C. Sec. 1407 to centralize this litigation in the Northern District of West Virginia. The litigation consists of six actions, as listed on Schedule A. One action is pending in the Central D . . .
* * *
In Re: Aflibercept Patent Litigation
TRANSFER ORDER
Before the Panel: Common plaintiff Regeneron Pharmaceuticals, Inc., moves under 28 U.S.C. Sec. 1407 to centralize this litigation in the Northern District of West Virginia. The litigation consists of six actions, as listed on Schedule A. One action is pending in the Central D . . .